Skip to main content

Table 3 Median age at the first, second, third, fourth and fifth dose of palivizumab dispensing

From: RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort study

Dose Number of infants Median age in days (IQR)
1st 271 39 (33–111)
2nd 191 67 (62–142)
3rd 106 96 (90–251)
4th 62 266 (121–372)
5th 47 318 (154–417)
  1. *IQR inter-quartile range